Stokes & Hubbell Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.8M | Buy |
37,752
+8
| +0% | +$382 | 0.38% | 56 |
|
|
2018
Q4 | $1.96M | Sell |
37,744
-704
| -2% | -$36.6K | 0.44% | 49 |
|
|
2018
Q3 | $2.39M | Buy |
38,448
+2,954
| +8% | +$183K | 0.49% | 49 |
|
|
2018
Q2 | $1.96M | Sell |
35,494
-2,609
| -7% | -$144K | 0.44% | 50 |
|
|
2018
Q1 | $2.41M | Buy |
38,103
+87
| +0.2% | +$5.5K | 0.56% | 47 |
|
|
2017
Q4 | $2.33M | Buy |
38,016
+158
| +0.4% | +$9.68K | 0.56% | 46 |
|
|
2017
Q3 | $2.41M | Buy |
37,858
+21,926
| +138% | +$1.4M | 0.62% | 44 |
|
|
2017
Q2 | $888K | Buy |
15,932
+2,632
| +20% | +$147K | 0.27% | 58 |
|
|
2017
Q1 | $723K | Buy |
13,300
+206
| +2% | +$11.2K | 0.25% | 60 |
|
|
2016
Q4 | $765K | Buy |
13,094
+2,855
| +28% | +$167K | 0.3% | 54 |
|
|
2016
Q3 | $552K | Buy |
10,239
+4
| +0% | +$216 | 0.23% | 61 |
|
|
2016
Q2 | $753K | Buy |
10,235
+953
| +10% | +$70.1K | 0.32% | 50 |
|
|
2016
Q1 | $593K | Buy |
9,282
+1,049
| +13% | +$67K | 0.27% | 49 |
|
|
2015
Q4 | $566K | Buy |
8,233
+3
| +0% | +$206 | 0.31% | 49 |
|
|
2015
Q3 | $487K | Buy |
+8,230
| New | +$487K | 0.3% | 48 |
|